Description
| Product Name | CAT.No | Details |
| MSUD | BXC0811A | 50T |
Product Description
The Biorex Diagnostics Maple Syrup Urine Disease (MSUD) Test is a high-quality neonatal screening assay designed for the early detection of MSUD, a rare but potentially life-threatening inborn error of metabolism. Simple, reliable, and highly sensitive, this test is ideal for clinical laboratories, hospitals, and newborn screening programmes to support timely diagnosis and intervention.
Key Features
• Neonatal-focused – compatible with dried blood spots, plasma, or serum for minimally invasive sampling
• Accurate quantification – measures leucine, isoleucine, valine, and alloisoleucine with precision
• Rapid and reliable results – enables timely clinical decisions and early dietary intervention
• High sensitivity and specificity – detects even mild elevations for early identification
• User-friendly – straightforward procedures suitable for high-throughput neonatal screening
• Laboratory integration – compatible with standard platforms and LIMS
• Cost-effective – tailored for large-scale newborn screening programmes
The Biorex Diagnostics MSUD Test provides a trusted, efficient, and clinically relevant solution for neonatal screening and early diagnosis of Maple Syrup Urine Disease. Its combination of accuracy, reliability, and simplicity supports early intervention, optimised workflow, and improved long-term health outcomes for affected infants.